Rite Aid is target of protest by unions - Union protest targets Rite Aid. - Drug Topics

ADVERTISEMENT

Rite Aid is target of protest by unions
Union protest targets Rite Aid.

Drug Topics E-News

More than 500 attendees at the recent International Foundation of Employee Benefit Plans Conference in Anaheim, Calif., protested Rite Aid by carrying bags that said, "Trust Rite Aid? Think Twice." Most of the attendees are involved in administering union healthcare and pension trusts. A labor coalition of 1199SEIU (Service Employees International Union), ILWU (International Longshore and Warehouse Union), and UFCW (United Food and Commercial Workers) was present at the conference. The unions claim that Rite Aid is violating its contractual obligations and federal labor law and running aggressive anti-union campaigns on the East and West coasts. At press time, Rite Aid had not responded to Drug Topics' request for comment.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, click here.

Drug Topics Issue
Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION

ADVERTISEMENT

ADVERTISEMENT

Survey
How much trouble do you have dealing with doctors' bad handwriting?
It's a minor inconvenience
It's a problem from time to time
It's a source of ongoing frustration
Don't get me started!
It's a minor inconvenience
9%
It's a problem from time to time
35%
It's a source of ongoing frustration
35%
Don't get me started!
21%
View Results

Modern Medicine logoDrug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.

Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.

ADVERTISEMENT

Source: Drug Topics E-News,
Click here